VALERIE COOPER: Open Payments
NPI 1144822644 · ROSEBURG, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$195 in 9 payments from 9 companies in 2025. Trend: 2023 $618 · 2024 $283 · 2025 $195
Food & beverage: $195
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 1 | $26 |
| Aveo Pharmaceuticals, Inc. | 1 | $25 |
| GENZYME CORPORATION | 1 | $24 |
| Janssen Biotech, Inc. | 1 | $23 |
| SERVIER PHARMACEUTICALS LLC | 1 | $22 |
| EMD Serono, Inc. | 1 | $20 |
| Daiichi Sankyo Inc. | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
| TerSera Therapeutics LLC | 1 | $18 |
Products named: BLENREP, FOTIVDA, SARCLISA, RYBREVANT, Tibsovo, Enhertu, OPDIVO, Quzyttir.
Industry payments across OR — which companies pay providers there.
